Graham Griffiths - 23 Jun 2022 Form 4 Insider Report for Vaccitech plc (BRNS)

Role: Chief Business Officer
Signature: /s/ William Enright, Attorney-in-Fact
Issuer symbol: BRNS
Transactions as of: 23 Jun 2022
Net transactions value: +$547
Form type: 4
Filing time: 15 Jul 2022, 16:05:58 UTC
Previous filing: 11 Feb 2022
Next filing: 15 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VACC	Ordinary Shares	Options Exercise	$0.7724	+1,931	+1.7%	$0.000400^*	117,830	23 Jun 2022	Direct	F1
transaction	VACC	Ordinary Shares	Options Exercise	$0.9268	+2,317	+2%	$0.000400^*	120,147	23 Jun 2022	Direct	F1
transaction	VACC	Ordinary Shares	Options Exercise	$1.24	+3,090	+2.6%	$0.000400^*	123,237	23 Jun 2022	Direct	F1
transaction	VACC	Ordinary Shares	Sale	$42.24	-8	-0.01%	$5.28	123,229	23 Jun 2022	Direct	F1, F2
transaction	VACC	Ordinary Shares	Small acquisition under Rule 16a-6	$587	+100	+0.08%	$5.87	123,329	24 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VACC	Share Option (Right to Buy)	Options Exercise	$0	-1,931	-100%	$0.000000^*	0	23 Jun 2022	Ordinary Shares	1,931	$0.000400	Direct	F1, F3
transaction	VACC	Share Option (Right to Buy)	Options Exercise	$0	-2,317	-50%	$0.000000	2,317	23 Jun 2022	Ordinary Shares	2,317	$0.000400	Direct	F1, F4
transaction	VACC	Share Option (Right to Buy)	Options Exercise	$0	-3,090	-33%	$0.000000	6,180	23 Jun 2022	Ordinary Shares	3,090	$0.000400	Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	These shares were sold to cover the exercise price of options exercised by the Reporting Person.
F3	This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
F4	This option shall vest and become exercisable in four equal annual installments, with the first installment vested on February 1, 2020. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
F5	This option shall vest and become exercisable in four equal annual installments, with the first installment vested on January 1, 2021. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3662 to GBP 1.00 on December 31, 2020.